Date post: | 08-Feb-2023 |
Category: |
Documents |
Upload: | khangminh22 |
View: | 0 times |
Download: | 0 times |
Affordability vs Quality of HealthcareHSBC Expat Explorer 2014
National Health Insurance since 1995,
99% coverage
2
臺灣總體環境的國際競爭力
4
總體經濟穩定(Macro-economic Stability)[2018 Global Competitiveness Report]
No. No.No.
投資環境風險(Environmental Risks ofInvestment)[2019 Environmental Risks of Investment]
No. /亞洲
No. /亞洲
全球經濟自由度(Index of Economic Freedom)
[2019 IEF]
健康照護系統(Health care systems)[2019 CEOWORLD magazine Health Care Index]
/亞洲No. No.
世界競爭力(World Competitiveness)
[2019 IMD]
/亞洲
/亞洲
醫療技術水準(Medical Technology)[National Geographic Channel Documentary:Taiwan’s medical miracle]
生技醫藥創新(Biopharmaceutical Innovation)[2018 Biopharmaceutical Competitiveness &Investment (BCI) Survey]
No.
全球創業指數(Global Entrepreneurship Index)[2018 Global Competitiveness Report]
行政院科技會報劉祖惠
3
臺灣生技醫藥的國際競爭力
臺灣競爭力領域 臨床試驗和研發能力 基礎科學研發與平臺設施 生技醫藥產官學間有效連結
臺灣的強項 執行能力 世界一流醫療人員及醫療品質 豐富的工程人才庫與研發能量 世界知名的製造業生態系統
張友德
5
8
8
14台灣醫院名列世界前200大醫院清單
*National Geographic Channel Documentary: Taiwan’s medical miracle
世界第31ST 美 國 2ND 德國
台灣特定疾病臨床試
驗合作聯盟(TCTC)
c-IRB聯合審查機制
(Collaborative IRB Review)
與國際同步
PIC/S GMP 規格
2021
16 9
34 38
17 17
47 4620
33
23 27
58 57
29
5129
35
29 36
55 52
127155
140129
111
185
177 190222
210214
243
0
50
100
150
200
250
300
350
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
台灣各類臨床試驗統計數字
Taiwan- single centerTaiwan- multiple centerMulti-national-multi-center
168
205
187 198174
238258
274
302
274
298
331
醫療技術
亞洲第 1
國際級臨床研究環境 建立國際級臨床研究環境,每年執行數百件臨床試驗,除支持台灣新藥開發外,
其中有7成係與跨國大廠的多國多中心臨床試驗,帶動在台投資,也與世界最先端研究合作同步。
6
臺灣-日本臨床試驗轉譯研究合作大事紀
5/28
9/21
舉辦第二屆臺日雙邊研習會 ARO-TCTC研習會議題:Cancer Translational Research and Cancer Registry Studies
第一屆臺日雙邊研習會 ARO-TCTC達成雙方輪流主辦兩國雙邊
生技醫藥合作研習會之共識
ARO協會成立
日本ARO成立2002
2015
2016
日本九州大學學者與ARO代表參訪中研院相關部門和TCTC
日本九州大學ARO代表拜會中研院和TCTC
Kyushu University/ARO Japan-Academia Sinica/TCTC雙邊研習會與代表擬定合作備忘錄內容
4/3
9/23
7/20
ARO代表拜會中研院、陽明及台大 TCTC Clinical informatics
8/31
8/19
Asian ARO Network Workshop
2/1
20175/13 第三屆臺日雙邊
研習會 ARO-TCTC
20185/11 第四屆臺日雙邊
研習會 ARO-TCTC
雙方規劃合作方向
2011
臺灣 NRPB 成立TCTC,13Consortium
2019 第五屆臺日雙邊研習會 ARO-TCTC
9/26TCTC-ARO
2015年12月 2016年12月 2017年12月 2018年12月
上市櫃家數 156家 170家 186家 188家
上市櫃營收 2127億 2413億 2508億 2788億
平均營收 13.64億 14.19億 13.48億 14.83億
上市櫃市值 1兆1538億 1兆0002億 9256億 8404億
平均市值 74億 59億 49.8億 44.7億
0
2000
4000
6000
8000
10000
12000
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
(億元;新台幣)
NRPBTCTC
Si2C
基亞浩鼎
10
有一手好牌如何才能打得更好
精準健康(Precision Health)才是生技產業的藍海
善用臺灣的優勢,突破坐擁金山的困境
結合 ICT 產業與生醫科技
人才培育更好有彈性,加強産學減少學用落差
民間資源的積極投入,光靠政府的力量是不夠的
法規制度的調整必需在心態上化被動為主動
國際化與國際鏈結,提升臺灣競爭力
12
Precision Health is the Future of Medicine精準健康是未來醫學的大趨勢
Using the tools of precision medicine, such as big data analytics and genomics, the goal of precision health is to predict, prevent and cure disease
American Hospital Association’s Leadership Summit 2019 14
Natural History of Disease and Precision Healthcare
疾病的自然史和精準健康照護
Time
Dis
eas
e b
urd
en
an
d C
ost
醫療
資源
耗費
Baseline Risk疾病風險
Earliest molecularDetection分子診斷
Earliest clinical
Detection最早臨床診斷
CurrentIntervention精準治療`
Irre
vers
ibili
ty
可逆
性
Baseline risk and susceptibility 風險評估
Monitor progressionRefine risk prediction
Define disease mechanisms
Monitor progressionRefine disease definition
Personalized therapy
Personalized Medicine Tools
Health Promotion健康促進 Prevention 疾病預防 Disease Management
疾病治療Precision Health Planning
Symptom 症狀
Modified from Snyderman R et al. NEJM Catalyst 2017
Precision Medicine精準醫學
15
上醫醫未病,中醫醫欲病,下醫醫已病(黃帝內經:Yellow Emperor Internal Classic, 2000+yrs ago)
史記記載,魏文王問扁鵲:「子昆弟三
人其孰最善為醫?」扁鵲曰:「長兄最
善,中兄次之,扁鵲最為下。」
魏文王曰:「可得聞邪?」
扁鵲曰: 「長兄於病視神,未有形而除之,
故名不出於家。中兄治病,其在毫毛,
故名不出於閭。若扁鵲者,鑱血脈,投
毒藥,副肌膚,閒而名出聞於諸侯。」
16
The supreme healer cures the illness that is still obscure,The good healer cures the illness that is about to break out,Fully manifested illness the least able tries to cure.
孫思邈(Sun Sijun, Tang Dynasty 581-682)
Global Precision Healthcare Market 2012-2025 (USD Billion)
精準健康照護之市場預測
0
500
1000
1500
2000
2500
3000
2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
PM Diagnostics PM Therapeutics Personalized Medical Care Personalized Nutrition & Wellness
641601
19精準醫療 健康福祉
Artificial Intelligence in Precision Medicine Market 2019 Top Compamnies: Intel AI, IBM, GE Healthcare, Thermo Fisher Scientific
Prachi Mahajan, QYReports 2019
“AI in Precision Medicine” refers to interactive and automated technology systems in the biotech industry, which can function autonomously with little or no human intervention.
20
Recent Advances of NGS Technology
23
Ion GS S5(www.thermofisher.com)
Hiseq4000(www.illumina.com)
PacBio RSII(www.pacb.com)
Roche 454 GS FLX(www.roche.com)
More reads Increase throughput Decrease turnaround times Increase read length
(Sara Goodwin, et al. Nat Rev Genet 2016)
SOLiD 5500xl WThermoFisher
Illumina iSeq100
Oxford Nanopore MinION
Semiconductor industry revenue by country (in billions of dollars)
台灣的半導體產業
0 50 100 150 200 250
Others
China
Europe
Japan
Taiwan
South Korea
U.S.
Taiwan Contributions:
Semiconductor: 20-25%
Sequencing chips: 20%
Personal communication, Dr. Frank Huang Chairman of Taiwan Semiconductor Industry Association
As of 2017 Source: IEK
24
The Evolution of Personalized Medicine 精準醫學檢測的演進
Clinical Pathways Interferes with Personalized Medicine
Image courtesy of the National Cancer Institute25
Clinical Proteomics臨床蛋白體學
26from Philipp E. Geyer et al. 2016 26
Modified from Kamalakaran S et al. Med Oncol 2013
Translating NGS and Omics to Point-of-Care次世代定序及體學應用於門診及床邊檢測
Point-of-care
Less invasive sample
Results quickly available
Risk prediction
Precision management
User friendly, lower cost
27
Risk assessment
Health Management
DiagnosisPrecision
TreatmentMedical Devices
Therapies
Medical Image• Digital Plat Panel• Non-invasive Endoscopy
Medical Supplies• Medical Cart System• Smart Patient Care System • Automated Dispensing Cabinet
Health Data Record Device• Wearable• Health Kiosk• AGEs, ViSi Mobile
Clinical Diagnostics
Radiotherapy• Photon Therapy (ZAP)• Proton Therapy (VARIAN)
Cell Therapy• Cell Therapy• NK-Cell Therapy• STEM-Cell Therapy
Health Check & Risk Prediction• Personal genome• Disease risk prediction• medical examination• Functional Medicine• Imaging/Nuclear Medicine
Food/Water/Air Testing Laboratory
Personal Health Cloud• Health Record Bank• Customer Health MGMT
Precision Medicine• Genetics• Environment• Life Style Optimization
Academy-Industry Cooperation HPC
Stem-CellCancer Gene Clinical Research
Precision Health
New Era of Precision Healthcare精準健康的新世代
28
EarlyDiagnosis
Health promotion
29
全人各階段的風險評估 整合型健康入口
資料分析 介入式
客製化監控
植入式 穿載式 智慧家庭 生物標記 影像
家庭史 基因篩檢 社經因素
學習和適應性
型態識別 機器學習方法 預測模型 數位孿生子 可行動反應的測定 醫生訪視
訓練和支援 特殊檢驗 精準醫療 行為改變
Precision Health Care Overview 精準健康的範疇
精準健康考慮到個人的基因、環境和生活方式的差異,並根據患者的獨特背景和條件製定治療和預防策略。
Sanjiv S. G. etc., Toward achieving precision health, Science Translational Medicine 2018
Monitoring on the body and in the home (I)
客製化智慧型居家自我健康監控
Sanjiv S. G. etc., Toward achieving precision health, Science Translational Medicine 2018 30
Monitoring on the body and in the home (II)
客製化智慧型居家自我健康監控
Sanjiv S. G. etc., Toward achieving precision health, Science Translational Medicine 2018 31
Precision Medicine in Taiwan 臺灣精準醫學的發展
DatabaseReagent,
Chips…Software Service Antibody Platform
New
TherapeuticsCRO/CDMO
Taiwan BioBank(Database)
National Health Insurance Database
Taiwan Clinical Trial Consortium
Laboratory Development Tests
Strong Government Support
Companies
R&D
Resources
Diagnostics Medicine
Universities Universities Universities Universities UniversitiesUniversities Universities Universities
Courtesy from Professor Dar-Bin Shieh 32
臺灣ICT大廠跨入大健康產業概況
遠距照護系統IoT設備/解決方案穿戴式裝置健康數據監測分析
與管理系統
Precision Healthcare Industry
基因與細胞療法行動健康照護 醫療設備與器材 智慧醫院解決方案
X光/超音波微型CT掃描儀手術/復健/輔助機器人膠囊內視鏡血液透析器臨床病理分子診斷生理監測設備
智慧病房/手術室手術3D導航/VR訓練AI解決方案行動醫護系統電子病歷/資訊系統醫療電腦/顯示器
基因定序儀基因定序檢測晶片蛋白質與基因檢測CTC檢測系統細胞療法
產品
應用技術
Genetic Medicine / Cell Therapy
企業
生醫關鍵元件
AI晶片基因定序晶片RF & Wireless chip體徵訊號感測器影像顯示元件有機半導體元件
資料來源:生策中心Source: Research Center for Biotechnology and Medicine Policy 33
36
Tailored treatment and
health management for
all
Taiwan Precision Medicine
Initiative
Pilot Project:
Genetic profiling of
1 million patients
Taiwan Precision
Medicine SNP array
Comprehensive clinical record
Taiwan reference
genomesPui-Yan Kwok
Courtesy from Kwok PY 2019
Use of HLA-B*58:01 genotyping to prevent allopurinol-induced severe cutaneous adverse reactions in Taiwan: national prospective study
BMJ 2015;351:h4848 Sep 23, 2015
Carbamazepine Allopurinol
HLA-B*15:02 HLA-B*58:01
37
Prevention of Drug Reactions
Stevens-Johnson Syndrome
and Toxic Epidermal Necrolysis
Courtesy from Kwok PY 2019
PharmacogeneticsExtensive
Metabolizer
(EM)
Intermediate
Metabolizer
(IM)
Poor
Metabolizer
(PM)
Cancer.gov
Questdiagnostics.com 38Courtesy from Kwok PY 2019
Low Risk PatientsScreening tests late
High Risk Patients
Change life style for
prevention
Screening tests early
Treat before symptomatic
39
Tailored Disease
Management
Courtesy from Kwok PY 2019
First FDA Clearance for Broad Oncology Imaging Suite with
Deep Learning
42
Automated nodule segmentation
Automated longitudinal tracking of nodules across multiple studies
https://arterys.com/lung
“Medical Selfies”:The Proliferation of Mobile Devices in Healthcare
Modified from Dr. George Poste 2017 43
外骨骼機器人投資工研院衍生新創-福寶科技與加拿大B-TEMIA 合資合作開發與協助ODM與美國Bionik簽署共同開發合作協議醫療與工業用外骨骼機器人合作開發體外檢測儀器
協助博錸生技儀量產製作專門設計、開發、製造體外診斷醫療(IVD) 產品與
ISO 驗證合格的儀器
生命科學儀器協助合作夥伴將CTC檢測儀器從原
型機系統縮小並進入量產
智慧醫療投資馬雅資訊,與馬偕醫院合作血透管理系統與恩主公醫院共同推動智慧醫院,設計數位醫療方案三大系統
光學與設備影像投資醫療影像系統服務商安盟生技協助業者將醫學影像儀器設計的更微小化與夥伴合作腫瘤影像AI判讀系統
46
Omics, AI and Precision Health at Point-of-Care
49
Microbiome
Big data
Machine Learning
Cognitive Computing
Liquid biopsyNGS
MicrofluidicsLab-on-a-Chip
Mini-MassOthers
P4 Medicine
以臺灣利基布局產業新未來
資訊硬體製造強
No.1 / 全球
總體經濟穩定
No.1 / 全球
生活品質
No.1 / 全球
BTC
利基優勢新未來
包容創新
永續
跨域合作引領產業創新
法規布局帶動產業發展
活絡資金加速產業動能
國際鏈結提升臺灣能見度
23
4
5
健康照護系統優異
No.1 / 全球
醫療水準高
No.1 / 亞洲
創新大國
No.1 / 亞洲
BTC 吳政忠政委 50